Skip to main content
Erschienen in: Wiener klinische Wochenschrift 23-24/2014

01.12.2014 | original article

Pneumocystis pneumonia (PCP) and Pneumocystis jirovecii carriage in renal transplantation patients: a single-centre experience

verfasst von: Matthias Maruschke, MD, Diana Riebold, PhD, Martha Charlotte Holtfreter, PhD, Martina Sombetzki, PhD, Steffen Mitzner, MD, Micha Loebermann, MD, Emil Christian Reisinger, MD, Oliver W. Hakenberg, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 23-24/2014

Einloggen, um Zugang zu erhalten

Summary

Background

The Pneumocystis pneumonia is an increasing problem in transplanted patients: up to 25 % suffer from Pneumocystis pneumonia, occurring during the first 6 months after transplantation.

Methods

From 2001 to 2009, we investigated 21 patients with pneumonia after renal transplantation for the presence of Pneumocystis jirovecii. The laboratory diagnosis was established by Grocott and Giemsa staining methods and Pneumocystis-specific mitochondrial transcribed large subunit nested polymerase chain reaction (PCR). The PCR was also used for the differentiation of Pneumocystis pneumonia from Pneumocystis carriage.

Results

Of 21 patients, 7 had a Pneumocystis pneumonia, 6 were Pneumocystis carriers and 8 patients were negative. Four out of seven Pneumocystis pneumonia patients and two out of six patients with Pneumocystis carriage had a delayed graft function. An acute cytomegalovirus infection after transplantation was not detectable in the patients with Pneumocystis pneumonia, but in three patients with Pneumocystis carriage.

Conclusions

Pneumocystis pneumonia was present in 33.3 % of transplanted patients with suspected pneumonia. An association between acute rejection or co-infections and Pneumocystis pneumonia or carriage in patients after renal transplantation cannot be excluded. In three out of seven Pneumocystis pneumonia patients, an overlapping of hospitalisation times and an onset of Pneumocystis pneumonia 6 months after transplantation was found. Thus, person-to-person transmission seems probable in these cases.
Literatur
1.
Zurück zum Zitat Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, Frederick T, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis. 2004;10:1713–20.PubMedCentralPubMedCrossRef Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, Frederick T, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis. 2004;10:1713–20.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Torres HA, Chemaly RF, Storey R, Aguilera EA, Nogueras GM, Safdar A, et al. Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Eur J Clin Microbiol Infect Dis. 2006;25:382–8.PubMedCrossRef Torres HA, Chemaly RF, Storey R, Aguilera EA, Nogueras GM, Safdar A, et al. Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Eur J Clin Microbiol Infect Dis. 2006;25:382–8.PubMedCrossRef
3.
Zurück zum Zitat Coyle PV, McCaughey C, Nager A, McKenna J, O’Neill H, Feeney SA, et al. Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immune-compromised patients may be becoming a significant problem. J Med Microbiol. 2012;61:1009–15.PubMedCrossRef Coyle PV, McCaughey C, Nager A, McKenna J, O’Neill H, Feeney SA, et al. Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immune-compromised patients may be becoming a significant problem. J Med Microbiol. 2012;61:1009–15.PubMedCrossRef
4.
Zurück zum Zitat Goto N, Oka S. Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl Infect Dis. 2011;13:551–8.PubMedCrossRef Goto N, Oka S. Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl Infect Dis. 2011;13:551–8.PubMedCrossRef
5.
Zurück zum Zitat Durand-Joly I, Chabe M, Soula F, Delhaes L, Camus D, Dei-Cas E. Molecular diagnosis of Pneumocystis pneumonia. FEMS Immunol Med Microbiol. 2005;45:405–10.PubMedCrossRef Durand-Joly I, Chabe M, Soula F, Delhaes L, Camus D, Dei-Cas E. Molecular diagnosis of Pneumocystis pneumonia. FEMS Immunol Med Microbiol. 2005;45:405–10.PubMedCrossRef
6.
Zurück zum Zitat Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis. 2008;197:10–7.PubMedCrossRef Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis. 2008;197:10–7.PubMedCrossRef
7.
Zurück zum Zitat Branten AJ, Beckers PJ, Tiggeler RG, Hoitsma AJ. Pneumocystis carinii pneumonia in renal transplant recipients. Nephrol Dial Transplant. 1995;10:1194–7.PubMed Branten AJ, Beckers PJ, Tiggeler RG, Hoitsma AJ. Pneumocystis carinii pneumonia in renal transplant recipients. Nephrol Dial Transplant. 1995;10:1194–7.PubMed
8.
Zurück zum Zitat Mori S, Cho I, Sugimoto M. A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis. J Rheumatol. 2009;36:1600–5.PubMedCrossRef Mori S, Cho I, Sugimoto M. A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis. J Rheumatol. 2009;36:1600–5.PubMedCrossRef
9.
Zurück zum Zitat Davis JL, Welsh DA, Beard CB, Jones JL, Lawrence GG, Fox MR, et al. Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia. Thorax. 2008;63:329–34.PubMedCrossRef Davis JL, Welsh DA, Beard CB, Jones JL, Lawrence GG, Fox MR, et al. Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia. Thorax. 2008;63:329–34.PubMedCrossRef
10.
Zurück zum Zitat Fritzsche C, Riebold D, Fuehrer A, Mitzner A, Klammt S, Mueller-Hilke B, et al. Pneumocystis jirovecii colonization among renal transplant recipients. Nephrology. 2013;18:382–7.PubMedCrossRef Fritzsche C, Riebold D, Fuehrer A, Mitzner A, Klammt S, Mueller-Hilke B, et al. Pneumocystis jirovecii colonization among renal transplant recipients. Nephrology. 2013;18:382–7.PubMedCrossRef
11.
Zurück zum Zitat Fritzsche C, Riebold D, Munk-Hartig A, Klammt S, Neeck G, Reisinger E. High prevalence of Pneumocystis jirovecii colonization among patients with autoimmune inflammatory diseases and corticosteroid therapy. Scand J Rheumatol. 2012;41:208–13.PubMedCrossRef Fritzsche C, Riebold D, Munk-Hartig A, Klammt S, Neeck G, Reisinger E. High prevalence of Pneumocystis jirovecii colonization among patients with autoimmune inflammatory diseases and corticosteroid therapy. Scand J Rheumatol. 2012;41:208–13.PubMedCrossRef
12.
Zurück zum Zitat Vernadakis S, Sotiropoulos GC, Brokalaki EI, Esser S, Kaiser GM, Cicinnati VR, et al. Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experience. Eur J Med Res. 2011;16:342–8.PubMedCentralPubMedCrossRef Vernadakis S, Sotiropoulos GC, Brokalaki EI, Esser S, Kaiser GM, Cicinnati VR, et al. Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experience. Eur J Med Res. 2011;16:342–8.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Le Gal S, Damiani C, Rouille A, Grall A, Treguer L, Virmaux M, et al. A cluster of Pneumocystis infections among renal transplant recipients: molecular evidence of colonized patients as potential infectious sources of Pneumocystis jiroveci. Clin Infect Dis. 2012;54:62–71.CrossRef Le Gal S, Damiani C, Rouille A, Grall A, Treguer L, Virmaux M, et al. A cluster of Pneumocystis infections among renal transplant recipients: molecular evidence of colonized patients as potential infectious sources of Pneumocystis jiroveci. Clin Infect Dis. 2012;54:62–71.CrossRef
14.
Zurück zum Zitat Chandola P, Lall M, Sen S, Bharadwaj R. Outbreak of Pneumocystis jirovecii pneumonia in renal transplant recipients on prophylaxis: our observation and experience. Indian J Med Microbiol. 2014;32:333–6.PubMedCrossRef Chandola P, Lall M, Sen S, Bharadwaj R. Outbreak of Pneumocystis jirovecii pneumonia in renal transplant recipients on prophylaxis: our observation and experience. Indian J Med Microbiol. 2014;32:333–6.PubMedCrossRef
15.
Zurück zum Zitat Riebold D, Löbermann M, Reisinger EC. Diagnostic features and resistance testing for Pneumocystis jirovecii. J Lab Med. 2008;32:35–9. Riebold D, Löbermann M, Reisinger EC. Diagnostic features and resistance testing for Pneumocystis jirovecii. J Lab Med. 2008;32:35–9.
16.
Zurück zum Zitat Procop GW, Haddad S, Quinn J, Wilson ML, Henshaw NG, Reller LB, et al. Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods. J Clin Microbiol. 2004;42:3333–5.PubMedCentralPubMedCrossRef Procop GW, Haddad S, Quinn J, Wilson ML, Henshaw NG, Reller LB, et al. Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods. J Clin Microbiol. 2004;42:3333–5.PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Sowden E, Carmichael AJ. Autoimmune inflammatory disorders, systemic corticosteroids and Pneumocystis pneumonia: a strategy for prevention. BMC Infect Dis. 2004;4:42.PubMedCentralPubMedCrossRef Sowden E, Carmichael AJ. Autoimmune inflammatory disorders, systemic corticosteroids and Pneumocystis pneumonia: a strategy for prevention. BMC Infect Dis. 2004;4:42.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Rabodonirina M, Vanhems P, Couray-Targe S, Gillibert RP, Ganne C, Nizard N, et al. Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients. Emerg Infect Dis. 2004;10:1766–73.PubMedCentralPubMedCrossRef Rabodonirina M, Vanhems P, Couray-Targe S, Gillibert RP, Ganne C, Nizard N, et al. Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients. Emerg Infect Dis. 2004;10:1766–73.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Hocker B, Wendt C, Nahimana A, Tonshoff B, Hauser PM. Molecular evidence of Pneumocystis transmission in pediatric transplant unit. Emerg Infect Dis. 2005;11:330–2.PubMedCentralPubMedCrossRef Hocker B, Wendt C, Nahimana A, Tonshoff B, Hauser PM. Molecular evidence of Pneumocystis transmission in pediatric transplant unit. Emerg Infect Dis. 2005;11:330–2.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat de Boer MG, Bruijnesteijn van Coppenraet LE, Gaasbeek A, Berger SP, Gelinck LB, van Houwelingen HC, et al. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis. 2007;44:1143–9. de Boer MG, Bruijnesteijn van Coppenraet LE, Gaasbeek A, Berger SP, Gelinck LB, van Houwelingen HC, et al. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis. 2007;44:1143–9.
21.
Zurück zum Zitat Schmoldt S, Schuhegger R, Wendler T, Huber I, Sollner H, Hogardt M, et al. Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation. J Clin Microbiol. 2008;46:966–71.PubMedCentralPubMedCrossRef Schmoldt S, Schuhegger R, Wendler T, Huber I, Sollner H, Hogardt M, et al. Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation. J Clin Microbiol. 2008;46:966–71.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Eitner F, Hauser IA, Rettkowski O, Rath T, Lopau K, Pliquett RU, et al. Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients. Nephrol Dial Transplant. 2011;26:2013–7.PubMedCrossRef Eitner F, Hauser IA, Rettkowski O, Rath T, Lopau K, Pliquett RU, et al. Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients. Nephrol Dial Transplant. 2011;26:2013–7.PubMedCrossRef
23.
Zurück zum Zitat Borstnar S, Lindic J, Tomazic J, Kandus A, Pikelj A, Prah J, et al. Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience. Transplant Proc. 2013;45:1614–7.PubMedCrossRef Borstnar S, Lindic J, Tomazic J, Kandus A, Pikelj A, Prah J, et al. Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience. Transplant Proc. 2013;45:1614–7.PubMedCrossRef
24.
Zurück zum Zitat Gordon SM, LaRosa SP, Kalmadi S, Arroliga AC, Avery RK, Truesdell-LaRosa L, et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis. 1999;28:240–6.PubMedCrossRef Gordon SM, LaRosa SP, Kalmadi S, Arroliga AC, Avery RK, Truesdell-LaRosa L, et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis. 1999;28:240–6.PubMedCrossRef
25.
Zurück zum Zitat Mitsides N, Greenan K, Green D, Middleton R, Lamerton E, Allen J, et al. Complications and outcomes of trimethoprim-sulphamethoxazole as chemoprophylaxis for Pneumocystis pneumonia in renal transplant recipients. Nephrology (Carlton). 2014;19:157–63.CrossRef Mitsides N, Greenan K, Green D, Middleton R, Lamerton E, Allen J, et al. Complications and outcomes of trimethoprim-sulphamethoxazole as chemoprophylaxis for Pneumocystis pneumonia in renal transplant recipients. Nephrology (Carlton). 2014;19:157–63.CrossRef
26.
Zurück zum Zitat Arend SM, Kroon FP, van’t Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med. 1995;155:2436–41. Arend SM, Kroon FP, van’t Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med. 1995;155:2436–41.
27.
Zurück zum Zitat Li JY, Yong TY, Grove DI, Coates PT. Late-onset and atypical presentation of Pneumocystis carinii pneumonia in a renal transplant recipient. Clin Exp Nephrol. 2009;13:92–5.PubMedCrossRef Li JY, Yong TY, Grove DI, Coates PT. Late-onset and atypical presentation of Pneumocystis carinii pneumonia in a renal transplant recipient. Clin Exp Nephrol. 2009;13:92–5.PubMedCrossRef
28.
Zurück zum Zitat Haidinger M, Hecking M, Memarsadeghi M, Weichhart T, Werzowa J, Horl WH, et al. Late onset Pneumocystis pneumonia in renal transplantation after long-term immunosuppression with belatacept. Transpl Infect Dis. 2009;11:171–4.PubMedCrossRef Haidinger M, Hecking M, Memarsadeghi M, Weichhart T, Werzowa J, Horl WH, et al. Late onset Pneumocystis pneumonia in renal transplantation after long-term immunosuppression with belatacept. Transpl Infect Dis. 2009;11:171–4.PubMedCrossRef
29.
Zurück zum Zitat Rezavand B, Hosseini MJ, Izadi M, Mahmoodzadeh Poornaki A, Sadraei J, Einollahi B, et al. Lethal Pneumocystis jiroveci pneumonia 24 years after kidney transplantation. Nephrourol Mon. 2014;6:e13605.PubMedCentralPubMed Rezavand B, Hosseini MJ, Izadi M, Mahmoodzadeh Poornaki A, Sadraei J, Einollahi B, et al. Lethal Pneumocystis jiroveci pneumonia 24 years after kidney transplantation. Nephrourol Mon. 2014;6:e13605.PubMedCentralPubMed
30.
Zurück zum Zitat EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.7.1 Late infections. Pneumocystis carinii pneumonia. Nephrol Dial Transplant. 2002;17(Suppl. 4):36–9. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.7.1 Late infections. Pneumocystis carinii pneumonia. Nephrol Dial Transplant. 2002;17(Suppl. 4):36–9.
31.
Zurück zum Zitat McCaughan JA, Courtney AE. Pneumocystis jiroveci pneumonia in renal transplantation: time to review our practice? Nephrol Dial Transplant. 2012;27:13–5.PubMedCrossRef McCaughan JA, Courtney AE. Pneumocystis jiroveci pneumonia in renal transplantation: time to review our practice? Nephrol Dial Transplant. 2012;27:13–5.PubMedCrossRef
32.
Zurück zum Zitat Arend SM, Westendorp RG, Kroon FP, van’t Wout JW, Vandenbroucke JP, van Es LA, et al. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients. Clin Infect Dis. 1996;22:920–5. Arend SM, Westendorp RG, Kroon FP, van’t Wout JW, Vandenbroucke JP, van Es LA, et al. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients. Clin Infect Dis. 1996;22:920–5.
33.
Zurück zum Zitat Radisic M, Lattes R, Chapman JF, del Carmen Rial M, Guardia O, Seu F, et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis. 2003;5:84–93.PubMedCrossRef Radisic M, Lattes R, Chapman JF, del Carmen Rial M, Guardia O, Seu F, et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis. 2003;5:84–93.PubMedCrossRef
34.
Zurück zum Zitat de Boer MG, Kroon FP, le Cessie S, de Fijter JW, van Dissel JT. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis. Transpl Infect Dis. 2011;13:559–69.PubMedCrossRef de Boer MG, Kroon FP, le Cessie S, de Fijter JW, van Dissel JT. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis. Transpl Infect Dis. 2011;13:559–69.PubMedCrossRef
35.
Zurück zum Zitat Arichi N, Kishikawa H, Mitsui Y, Kato T, Nishimura K, Tachikawa R, et al. Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center. Transplant Proc. 2009;41:170–2.PubMedCrossRef Arichi N, Kishikawa H, Mitsui Y, Kato T, Nishimura K, Tachikawa R, et al. Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center. Transplant Proc. 2009;41:170–2.PubMedCrossRef
36.
Zurück zum Zitat Adlakha A, Pavlou M, Walker DA, Copas AJ, Dufty N, Batson S, et al. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy. Int J STD AIDS. 2011;22:498–504.PubMedCrossRef Adlakha A, Pavlou M, Walker DA, Copas AJ, Dufty N, Batson S, et al. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy. Int J STD AIDS. 2011;22:498–504.PubMedCrossRef
37.
Zurück zum Zitat Chabe M, Dei-Cas E, Creusy C, Fleurisse L, Respaldiza N, Camus D, et al. Immunocompetent hosts as a reservoir of Pneumocystis organisms: histological and rt-PCR data demonstrate active replication. Eur J Clin Microbiol Infect Dis. 2004;23:89–97.PubMedCrossRef Chabe M, Dei-Cas E, Creusy C, Fleurisse L, Respaldiza N, Camus D, et al. Immunocompetent hosts as a reservoir of Pneumocystis organisms: histological and rt-PCR data demonstrate active replication. Eur J Clin Microbiol Infect Dis. 2004;23:89–97.PubMedCrossRef
38.
Zurück zum Zitat Medrano FJ, Montes-Cano M, Conde M, de la Horra C, Respaldiza N, Gasch A, et al. Pneumocystis jirovecii in general population. Emerg Infect Dis. 2005;11:245–50.PubMedCentralPubMedCrossRef Medrano FJ, Montes-Cano M, Conde M, de la Horra C, Respaldiza N, Gasch A, et al. Pneumocystis jirovecii in general population. Emerg Infect Dis. 2005;11:245–50.PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat de Boer MG, Kroon FP, le Cessie S, de Fijter JW, van Dissel JT. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis. Transpl Infect Dis. 2011;13(6):559–69. de Boer MG, Kroon FP, le Cessie S, de Fijter JW, van Dissel JT. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis. Transpl Infect Dis. 2011;13(6):559–69.
40.
Zurück zum Zitat Debourgogne A, Favreau S, Ladriere M, Bourry S, Machouart M. Characteristics of Pneumocystis pneumonia in Nancy from January 2007 to April 2011 and focus on an outbreak in nephrology. J Mycol Med. 2014;24:19–24.PubMedCrossRef Debourgogne A, Favreau S, Ladriere M, Bourry S, Machouart M. Characteristics of Pneumocystis pneumonia in Nancy from January 2007 to April 2011 and focus on an outbreak in nephrology. J Mycol Med. 2014;24:19–24.PubMedCrossRef
41.
Zurück zum Zitat Damiani C, Choukri F, Le Gal S, Menotti J, Sarfati C, Nevez G, et al. Possible nosocomial transmission of Pneumocystis jirovecii. Emerg Infect Dis. 2012;18:877–8.PubMedCentralPubMedCrossRef Damiani C, Choukri F, Le Gal S, Menotti J, Sarfati C, Nevez G, et al. Possible nosocomial transmission of Pneumocystis jirovecii. Emerg Infect Dis. 2012;18:877–8.PubMedCentralPubMedCrossRef
42.
Zurück zum Zitat Brunot V, Pernin V, Chartier C, Garrigue V, Vetromile F, Szwarc I, et al. An epidemic of Pneumocystis jiroveci pneumonia in a renal transplantation center: role of T-cell lymphopenia. Transplant Proc. 2012;44:2818–20.PubMedCrossRef Brunot V, Pernin V, Chartier C, Garrigue V, Vetromile F, Szwarc I, et al. An epidemic of Pneumocystis jiroveci pneumonia in a renal transplantation center: role of T-cell lymphopenia. Transplant Proc. 2012;44:2818–20.PubMedCrossRef
Metadaten
Titel
Pneumocystis pneumonia (PCP) and Pneumocystis jirovecii carriage in renal transplantation patients: a single-centre experience
verfasst von
Matthias Maruschke, MD
Diana Riebold, PhD
Martha Charlotte Holtfreter, PhD
Martina Sombetzki, PhD
Steffen Mitzner, MD
Micha Loebermann, MD
Emil Christian Reisinger, MD
Oliver W. Hakenberg, MD
Publikationsdatum
01.12.2014
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 23-24/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-014-0608-3

Weitere Artikel der Ausgabe 23-24/2014

Wiener klinische Wochenschrift 23-24/2014 Zur Ausgabe